rs147339483

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001069.3(TUBB2A):​c.504C>T​(p.Ser168Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00109 in 1,612,650 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0055 ( 6 hom., cov: 30)
Exomes 𝑓: 0.00063 ( 11 hom. )

Consequence

TUBB2A
NM_001069.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.612
Variant links:
Genes affected
TUBB2A (HGNC:12412): (tubulin beta 2A class IIa) Microtubules, key participants in processes such as mitosis and intracellular transport, are composed of heterodimers of alpha- and beta-tubulins. The protein encoded by this gene is a beta-tubulin. Defects in this gene are associated with complex cortical dysplasia with other brain malformations-5. Two transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 6-3154697-G-A is Benign according to our data. Variant chr6-3154697-G-A is described in ClinVar as [Benign]. Clinvar id is 212496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-3154697-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.612 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0055 (834/151606) while in subpopulation AFR AF= 0.0187 (776/41434). AF 95% confidence interval is 0.0176. There are 6 homozygotes in gnomad4. There are 378 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High AC in GnomAd4 at 834 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TUBB2ANM_001069.3 linkc.504C>T p.Ser168Ser synonymous_variant Exon 4 of 4 ENST00000333628.4 NP_001060.1 Q13885
TUBB2ANM_001310315.2 linkc.249C>T p.Ser83Ser synonymous_variant Exon 4 of 4 NP_001297244.1 Q13885

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TUBB2AENST00000333628.4 linkc.504C>T p.Ser168Ser synonymous_variant Exon 4 of 4 1 NM_001069.3 ENSP00000369703.2 Q13885

Frequencies

GnomAD3 genomes
AF:
0.00552
AC:
836
AN:
151486
Hom.:
6
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0188
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00236
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000210
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0000738
Gnomad OTH
AF:
0.00581
GnomAD3 exomes
AF:
0.00148
AC:
372
AN:
250520
Hom.:
2
AF XY:
0.00105
AC XY:
142
AN XY:
135470
show subpopulations
Gnomad AFR exome
AF:
0.0195
Gnomad AMR exome
AF:
0.00116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000653
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000797
Gnomad OTH exome
AF:
0.000818
GnomAD4 exome
AF:
0.000630
AC:
921
AN:
1461044
Hom.:
11
Cov.:
34
AF XY:
0.000577
AC XY:
419
AN XY:
726712
show subpopulations
Gnomad4 AFR exome
AF:
0.0221
Gnomad4 AMR exome
AF:
0.00121
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000128
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000162
Gnomad4 OTH exome
AF:
0.00146
GnomAD4 genome
AF:
0.00550
AC:
834
AN:
151606
Hom.:
6
Cov.:
30
AF XY:
0.00510
AC XY:
378
AN XY:
74072
show subpopulations
Gnomad4 AFR
AF:
0.0187
Gnomad4 AMR
AF:
0.00236
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000210
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000738
Gnomad4 OTH
AF:
0.00575
Alfa
AF:
0.00197
Hom.:
0
Bravo
AF:
0.00645
EpiCase
AF:
0.000109
EpiControl
AF:
0.0000594

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 22, 2017
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Aug 30, 2016
Genetic Services Laboratory, University of Chicago
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
11
DANN
Benign
0.89

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs147339483; hg19: chr6-3154931; API